Göril Karlsson - Concepedia

Author

Göril Karlsson

Novartis (Switzerland)

Also Known As

Goril Karlsson, Göril Karlsson

Publications

555

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Université de Lille Queen Mary University of London University of Basel University of Pennsylvania

About

Göril Karlsson is an author at Novartis (Switzerland) specializing in neuropharmacology, medicine, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	390
2	Social Sciences	3	3	56
3	Neurology	2	2	39
4	Health Sciences	1	1	17
5	Behavioral Sciences	1	1	17

Göril Karlsson

Publications

554

Citations

H-Index

Page 1

	Year	Citations
CGP 35348: a centrally active blocker of GABAB receptors Hans-Rudolf Olpe, Göril Karlsson, Mario F. Pozza, European Journal of Pharmacology Molecular PharmacologyG Protein-coupled ReceptorMedicineFunctional SelectivityReceptor (Biochemistry)	1990	309
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis Ralph H. B. Benedict, Davorka Tomic, Bruce Cree, Neurology	2021	77
Phaclofen: a GABAB blocker reduces long-duration inhibition in the neocortex Göril Karlsson, Mario F. Pozza, Hans-Rudolf Olpe European Journal of Pharmacology MedicineMechanism Of ActionPharmacological AgentNeuropharmacologyExperimental Pharmacology	1988	42
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial Douglas L. Arnold, Daniela Piani-Meier, Amit Bar‐Or, Multiple Sclerosis Journal	2022	32
Inhibitory processes in normal and epileptic-like rat hippocampal slices: the role of GABAB receptors Göril Karlsson, Hans-Rudolf Olpe European Journal of Pharmacology Gabab ReceptorsSynaptic PlasticityNeurophysiologyMedicineNeurotransmitter	1989	27
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis Bruce Cree, Baldur Magnusson, Nicolas Rouyrre, Multiple Sclerosis Journal	2020	21
Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats Göril Karlsson, Anne-Lise Jaton, J. M. Vigouret Neuroscience Letters Behavioral SciencesPsychoactive DrugBehavioral NeuroscienceBehavioural PharmacologyNeurotransmitter	1988	17
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study Ralf Gold, Daniela Piani-Meier, Ludwig Kappos, Journal of Neurology	2022	17
Impact of Siponimod on Cognition in Patients With Secondary Progressive Multiple Sclerosis: Results From Phase 3 EXPAND Study (S44.004) Ralph H. B. Benedict, Bruce Cree, Davorka Tomic, Neurology NeuropsychologyNeurological FunctioningCognitive PerformanceExpand StudyMedicine	2018	12

Page 1